What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001922318
Total reported value
$1.4B
$1.4B
60 檔
75.3%
The Q4 2025 SEC filing reveals that Pale Fire Capital SE held a total portfolio value of $1.4B, covering 60 public equity positions.
In Q4 2025, Pale Fire Capital SE displayed an active expansion posture, initiating 25 new positions and adding to 18 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including COIN, TSLA, HOOD) accounted for 75.3% of total reported equity market value during Q4 2025.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | COIN | Coinbase Global Inc -class A | Stock-Financials | 19.30% | — | — | |
| 2 | TSLA | Tesla Inc | Stock-Consumer Disc | 15.70% | — | — | |
| 3 | HOOD | Robinhood Markets Inc - A | Stock-Financials | 12.57% | — | — | |
| 4 | GRPN | Groupon Inc | Stock-Other | 12.03% | +6.67% | — | |
| 5 | BTG | B2gold CORP | Stock-Other | 11.90% | -10.69% | -21.40% | |
| 6 | DOLE | Dole plc | Stock-Other | 9.43% | -2.69% | +9.14% | |
| 7 | ZD | Ziff Davis Inc | Stock-Other | 2.85% | -0.41% | +201.11% | |
| 8 | BAX | Baxter International Inc | Stock-Healthcare | 2.66% | -2.34% | EXIT | |
| 9 | IAUX | I-80 Gold CORP | Stock-Other | 2.03% | -0.86% | -8.21% | |
| 10 | ANGI | Angi Inc | Stock-Other | 1.87% | -0.72% | +57.32% | |
| 11 | GAU | Galiano Gold Inc | Stock-Other | 1.34% | -0.21% | +18.91% | |
| 12 | TDOC | Teladoc Health Inc | Stock-Healthcare | 0.91% | -0.45% | — | |
| 13 | LQDA | Liquidia CORP | Stock-Other | 0.88% | -1.27% | +57.61% | |
| 14 | CGAU | Centerra Gold Inc | Stock-Other | 0.57% | — | -74.69% | |
| 15 | CARS | Cars.com Inc | Stock-Other | 0.54% | +0.28% | — | |
| 16 | RGNX | Regenxbio Inc | Stock-Other | 0.48% | +0.03% | +95.43% | |
| 17 | GUTS | Fractyl Health Inc | Stock-Other | 0.47% | +0.04% | — | |
| 18 | TEN | Tsakos Energy Navigation Limited | Stock-Other | 0.45% | — | -13.13% | |
| 19 | GERN | Geron CORP | Stock-Other | 0.42% | -0.16% | +109.86% | |
| 20 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 0.40% | -0.39% | — | |
| 21 | TECX | Tectonic Therapeutic Inc | Stock-Other | 0.37% | — | +0.50% | |
| 22 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.34% | — | +79.88% | |
| 23 | KURA | Kura Oncology Inc | Stock-Other | 0.32% | -0.57% | -25.59% | |
| 24 | PPLI | People Inc | Stock-Comm Services | 0.25% | -0.19% | EXIT | |
| 25 | DERM | Journey Medical CORP | Stock-Other | 0.23% | +0.06% | +94.53% | |
| 26 | OEF | Ishares S&p 100 ETF | ETF-Other | 0.22% | — | — | |
| 27 | WIX | Wix.com Ltd. | Stock-Tech | 0.22% | — | — | |
| 28 | CMRC | Commerce.com Inc | Stock-Other | 0.21% | -0.05% | +150.79% | |
| 29 | NVDA | Nvidia CORP | Stock-Tech | 0.14% | — | — | |
| 30 | HRTX | Heron Therapeutics Inc | Stock-Other | 0.13% | -0.11% | +211.90% | |
| 31 | SGMT | Sagimet Biosciences Inc-a | Stock-Other | 0.09% | +0.02% | — | |
| 32 | HELP | Cybin Inc | Stock-Other | 0.08% | +0.01% | — | |
| 33 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.06% | +0.01% | — | |
| 34 | ✓ | Adeco Agro | Stock-Other | 0.05% | — | — | |
| 35 | XFOR | X4 Pharmaceuticals Inc | Stock-Other | 0.04% | -0.06% | EXIT | |
| 36 | LFCR | Lifecore Biomedical Inc | Stock-Other | 0.04% | — | +9.94% | |
| 37 | HROW | Harrow Inc | Stock-Other | 0.04% | — | +45.62% | |
| 38 | PESI | Perma-fix Environmental Svcs | Stock-Other | 0.04% | +0.01% | -4.53% | |
| 39 | DCTH | Delcath Systems Inc | Stock-Other | 0.03% | +0.01% | — | |
| 40 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.03% | +0.30% | -98.06% | |
| 41 | CRTO | Criteo Sa-spon Adr | Stock-Other | 0.03% | — | — | |
| 42 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 0.02% | -0.04% | EXIT | |
| 43 | ONIT | Onity Group Inc | Stock-Other | 0.02% | — | — | |
| 44 | PTHS | Pelthos Therapeutics Inc | Stock-Other | 0.02% | +0.01% | — | |
| 45 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.02% | +0.01% | — | |
| 46 | LXEO | Lexeo Therapeutics Inc | Stock-Other | 0.01% | — | -33.72% | |
| 47 | ✓ | Engene Holdings Inc | Stock-Other | 0.01% | -0.01% | EXIT | |
| 48 | RLMD | Relmada Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 49 | VZLA | Vizsla Silver CORP | Stock-Other | 0.01% | — | +24.32% | |
| 50 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 0.01% | +0.01% | -65.34% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ZD | Ziff Davis Inc | +1.2% | +201.11% | Add |
| 2 | LQDA | Liquidia CORP | +0.3% | +57.61% | Add |
| 3 | RGNX | Regenxbio Inc | +0.2% | +95.43% | Add |
| 4 | DAWNGBX | Day One Biopharmaceuticals I | +0.1% | +79.88% | Add |
| 5 | GERN | Geron CORP | +0.1% | +109.86% | Add |
| 6 | HRTX | Heron Therapeutics Inc | +0.1% | +211.90% | Add |
| 7 | DERM | Journey Medical CORP | +0.1% | +94.53% | Add |
| 8 | CMRC | Commerce.com Inc | +0.1% | +150.79% | Add |
| 9 | HROW | Harrow Inc | — | +45.62% | Add |
| 10 | CGEM | Cullinan Therapeutics Inc | — | +32.18% | Add |
| 11 | ✓ | Engene Holdings Inc | — | +39.12% | Add |
| 12 | VZLA | Vizsla Silver CORP | — | +24.32% | Add |
| 13 | NEWP | New Pacific Metals CORP | — | +9.62% | Add |
| 14 | LFCR | Lifecore Biomedical Inc | 0% | +9.94% | Add |
| 15 | PESI | Perma-fix Environmental Svcs | 0% | -4.53% | Trim |
| 16 | LRMR | Larimar Therapeutics Inc | 0% | — | Unchanged |
| 17 | LXEO | Lexeo Therapeutics Inc | 0% | -33.72% | Trim |
| 18 | HELP | Cybin Inc | 0% | — | Unchanged |
| 19 | ✓ | Immatics NV | 0% | -52.52% | Trim |
| 20 | RZLT | Rezolute Inc | 0% | -20.04% | Trim |
| 21 | XFOR | X4 Pharmaceuticals Inc | 0% | -7.33% | Trim |
| 22 | ✓ | Adeco Agro | 0% | — | Unchanged |
| 23 | TARS | Tarsus Pharmaceuticals Inc | 0% | -65.34% | Trim |
| 24 | TECX | Tectonic Therapeutic Inc | -0.1% | +0.50% | Add |
| 25 | GAU | Galiano Gold Inc | -0.3% | +18.91% | Add |
| 26 | KURA | Kura Oncology Inc | -0.3% | -25.59% | Trim |
| 27 | IAUX | I-80 Gold CORP | -0.3% | -8.21% | Trim |
| 28 | TEN | Tsakos Energy Navigation Limited | -0.4% | -13.13% | Trim |
| 29 | ANGI | Angi Inc | -0.6% | +57.32% | Add |
| 30 | ATAI | AtaiBeckley Inc. | -0.6% | -95.76% | Trim |
| 31 | CGAU | Centerra Gold Inc | -2.2% | -74.69% | Trim |
| 32 | MLYS | Mineralys Therapeutics Inc | -2.2% | -98.06% | Trim |
| 33 | DOLE | Dole plc | -3.2% | +9.14% | Add |
| 34 | GRPN | Groupon Inc | -14% | — | Unchanged |
| 35 | BTG | B2gold CORP | -15.2% | -21.40% | Trim |
| 36 | COIN | Coinbase Global Inc -class A | — | NEW | New buy |
| 37 | TSLA | Tesla Inc | — | NEW | New buy |
| 38 | HOOD | Robinhood Markets Inc - A | — | NEW | New buy |
| 39 | IAG | Iamgold CORP | — | EXIT | Sold out |
| 40 | NGDN | New Gold Inc | — | EXIT | Sold out |
| 41 | BAX | Baxter International Inc | — | NEW | New buy |
| 42 | TEVA | Teva Pharmaceutical-sp Adr | — | EXIT | Sold out |
| 43 | TDOC | Teladoc Health Inc | — | NEW | New buy |
| 44 | CARS | Cars.com Inc | — | NEW | New buy |
| 45 | GUTS | Fractyl Health Inc | — | NEW | New buy |
| 46 | SNDX | Syndax Pharmaceuticals Inc | — | NEW | New buy |
| 47 | NUVB | Nuvation Bio Inc | — | EXIT | Sold out |
| 48 | PPLI | People Inc | — | NEW | New buy |
| 49 | INSW | International Seaways, Inc. | — | EXIT | Sold out |
| 50 | OEF | Ishares S&p 100 ETF | — | NEW | New buy |
According to official SEC Form 13F filings, Pale Fire Capital SE reported a total U.S. public equity portfolio value of $1.4B across 60 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
COIN
市值: $287.6M
Top Position Liquidated / Trimmed
IAG
前期市值: $50.8M
During Q4 2025, Pale Fire Capital SE's top holdings by market value included COIN (19.3%)、TSLA (15.7%)、HOOD (12.6%). The largest single position, COIN, represented 19.3% of total portfolio value.
In Q4 2025, Pale Fire Capital SE made 75 total portfolio adjustments, initiating 25 new buys, adding to 18 positions, trimming 13 holdings, and fully liquidating 19 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.